Wijermans P - Search Results

1

Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial.

Stevens-Kroef MJ, Olde Weghuis D, ElIdrissi-Zaynoun N, van der Reijden B, Cremers EMP, Alhan C, Westers TM, Visser-Wisselaar HA, Chitu DA, Cunha SM, Vellenga E, Klein SK, Wijermans P, de Greef GE, Schaafsma MR, Muus P, Ossenkoppele GJ, van de Loosdrecht AA, Jansen JH. Stevens-Kroef MJ, et al. Among authors: wijermans p. Genes Chromosomes Cancer. 2017 Jul;56(7):524-534. doi: 10.1002/gcc.22455. Epub 2017 Mar 31. Genes Chromosomes Cancer. 2017. PMID: 28236351 Clinical Trial.

2

Monocytic differentiation induction of HL-60 cells by MC 903, a novel vitamin D analogue.

Rebel VI, Ossenkoppele GJ, van de Loosdrecht AA, Wijermans PW, Beelen RH, Langenhuijsen MM. Rebel VI, et al. Among authors: wijermans pw. Leuk Res. 1992;16(5):443-51. doi: 10.1016/0145-2126(92)90169-8. Leuk Res. 1992. PMID: 1625469

3

Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicity.

Ossenkoppele GJ, Wijermans PW, Nauta JJ, Huijgens PC, Langenhuijsen MM. Ossenkoppele GJ, et al. Among authors: wijermans pw. Eur J Cancer. 1991;27(7):842-5. doi: 10.1016/0277-5379(91)90130-6. Eur J Cancer. 1991. PMID: 1834114

4

Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies.

Huijgens PC, Ossenkoppele GJ, Weijers TF, van Loenen AC, Simoons-Smit AM, Wijermans PW, van Pampus EC, Langenhuijsen MM. Huijgens PC, et al. Among authors: wijermans pw. Eur J Haematol. 1991 Jan;46(1):42-6. doi: 10.1111/j.1600-0609.1991.tb00512.x. Eur J Haematol. 1991. PMID: 1988306 Clinical Trial.

5

Chemotherapy in non-Hodgkin's lymphoma during pregnancy.

Lambert J, Wijermans PW, Dekker GA, Ossenkoppele GJ. Lambert J, et al. Among authors: wijermans pw. Neth J Med. 1991 Feb;38(1-2):80-5. Neth J Med. 1991. PMID: 2030816

6

Longterm meningeal involvement as the only clinical manifestation of low grade malignant non-Hodgkin's lymphoma.

Heimans JJ, Wijermans PW, Polman CH, Huijgens PC, Ossenkoppele GJ, van Kamp GJ. Heimans JJ, et al. Among authors: wijermans pw. J Neurooncol. 1990 Dec;9(3):275-7. doi: 10.1007/BF02341158. J Neurooncol. 1990. PMID: 2086741

7

Purification of human megakaryocytes using a glycoprotein Ib dependent agglutination technique.

van Pampus EC, Huijgens PC, Wijermans PW, Ossenkoppele GJ, Langenhuijsen MM. van Pampus EC, et al. Among authors: wijermans pw. Clin Lab Haematol. 1990;12(3):301-7. doi: 10.1111/j.1365-2257.1990.tb00040.x. Clin Lab Haematol. 1990. PMID: 2272159

8

Maturation induction in freshly isolated human myeloid leukemic cells, 1.25 (OH)2 vitamin D3 being the most potent inducer.

Ossenkoppele GJ, Wijermans PW, Nauta JJ, Huijgens PC, Langenhuijsen MM. Ossenkoppele GJ, et al. Among authors: wijermans pw. Leuk Res. 1989;13(7):609-14. doi: 10.1016/0145-2126(89)90129-x. Leuk Res. 1989. PMID: 2548044

9

Low dose cytosine-arabinoside has only minimal differentiation inducing capacity in HL60 cells.

Ossenkoppele GJ, Wijermans PW, de Waal FC, vd Berg TA, Jalink W, Huijgens PC, Langenhuijsen MM. Ossenkoppele GJ, et al. Among authors: wijermans pw. Eur J Cancer Clin Oncol. 1989 Nov;25(11):1561-9. doi: 10.1016/0277-5379(89)90298-8. Eur J Cancer Clin Oncol. 1989. PMID: 2591448

10

Standard induction and low dose ara-C treatment in patients over 60 with AML or MDS.

van Geel BM, Huijgens PC, Ossenkoppele GJ, Wijermans PW, Langenhuijsen MM. van Geel BM, et al. Among authors: wijermans pw. Neth J Med. 1989 Oct;35(3-4):128-36. Neth J Med. 1989. PMID: 2601790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters